COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1106: Articles 11051-11060  | Next

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
Evans, J. P., Zeng, C., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., Liu, S.-L.
10.1101/2021.12.06.471455 — Posted: 2021-12-07
Engineering RNA viruses with unnatural amino acid to evoke adjustable immune response in mice
Zheng, Z., Wang, Y., Wu, X., Zhang, H., Chen, H., Lin, H., Shen, Y., Xia, Q.
10.1101/2021.12.04.471206 — Posted: 2021-12-07
The Impact of Mass Exodus on the Resurgence of COVID19 Cases: Study Case of Regions in Indonesia
Nuraini, N., Sukandar, K. K., Aini, W.
10.1101/2021.12.06.21267391 — Posted: 2021-12-07
Systematic review of cardiac adverse effects in children and young people un-der 18 years of age after SARS-CoV-2 vaccination
Cruz, J., Duret, A., Harwood, R., Fraser, L. K., Jones, C. B., Ward, J., Whittaker, E., Kenny, S. E., Vinner, R. M.
10.1101/2021.12.06.21267339 — Posted: 2021-12-07
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
Li, D., Cheng, S., Debbas, P., Braun, J., McGovern, D. P. B., Melmed, G. Y., CORALE-IBD Study Group
10.1101/2021.12.05.21266089 — Posted: 2021-12-07
Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings
Chandna, A., Mahajan, R., Gautam, P., Mwandigha, L., Gunasekaran, K., Bhusan, D., Cheung, A. T. L., Day, N., Dittrich, S., Dondorp, A., Geevar, T., Ghattamaneni, S. R., Hussain, S., Jimenez, C., Karthikeyan, R., Kumar, S., Kumar, S., Kumar, V., Kundu, D., Lakshmanan, A., Manesh, A., Menggred, C., Moorthy, M., Osborn, J., Richard-Greenblatt, M., Sharma, S., Singh, V. K., Singh, V. K., Suri, J., Suzuki, S., Tubprasert, J., Turner, P., Villanueva, A. M. G., Waithira, N., Kumar, P., Varghese, G. M., Koshiaris, C., Lubell, Y., Burza, S.
10.1101/2021.12.02.21267170 — Posted: 2021-12-07
Individual vaccine efficacy variation with time since mRNA BNT162b2 vaccination estimated by rapid, quantitative antibody measurements from a finger-prick sample.
Vargas, M. J., Chandrasekhar, M., Kwon, Y. J., Deijs, G. S., Corazza, C. M. O. W., Chai, A., Binedell, R. L., Jose, E., Govind, B., Huyet, L., Patel, P. K., Reshef, G., Kumar, V., Lowe, T., Powell, R. J., Jina, K. C., Walker, F. C. W., Talemaitoga, A., Simpson, M. C., Williams, D. E.
10.1101/2021.11.30.21267102 — Posted: 2021-12-07
A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing
Savage, H. R., Finch, L., Body, R., Watkins, R. L., LSTM Diagnostics Group, , CONDOR steering group, , Hayward, G., Cook, E., Cubas Atienzar, A. I., Cuevas, L., MacPherson, P., Adams, E. R.
10.1101/2021.12.06.21267356 — Posted: 2021-12-07
Predicted CTL responses from pressured epitopes in SARS-CoV-2 correlate with COVID-19 severity
Rao, V. N., Banerjee, U., Sambaturu, N., Chunchanur, S., R, A., Chandra, N.
10.1101/2021.12.06.21267084 — Posted: 2021-12-07
SIR Modeling the Dual Disaster Impacts of Omicron B.1.1.529 and Natural Disaster Events on Simulated 6 Months (from December 2021 to May 2022) Healthcare System Resiliences in Fragile SE Asia Ring of Fire Ecosystems
Wibowo, A. A.
10.1101/2021.12.07.21267405 — Posted: 2021-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).